Virtual Medicinal Product (VMP) - Progesterone 2.34% transdermal cream
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Progesterone 2.34% transdermal cream | Start Date 03-10-2023 | End Date |
| Previous Name | Previous Name Progesterone 2.34% cream | Start Date 20-06-2012 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Transdermal
- Form
- Transdermal cream
- Ontology Form/Route
- cream.transdermal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- G03DA04
- BNF Codes
-
- BNF code 06040102
| Code | Start Date | End Date |
|---|---|---|
| 20921211000001106 | 20-06-2012 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Progesterone | Based on Ingredient Substance | 23.4 mg | 1 gram |
Name
Progesterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
23.4
Strength and UOM (Dmr)
1
Parent Products
-
VTMProgesterone
-
VMP(Current) Progesterone 2.34% transdermal cream
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 60 gram |